Medication info
Telmisartan/Amlodipine Tablets 40/5 mg

Telmisartan/Amlodipine Tablets 40/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
Biconvex oval double-coated tablet in white and pale blue.
Packaging
30 tablets/box [10 tablets/PTP*3], 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201606818 · Approved 2016.11.30 · Insurance code 650303600

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Child dose
Pediatric patients 18 years of age or younger: The safety and efficacy of this medicine have not been established; therefore, its use is not recommended.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used when blood pressure is not adequately controlled with telmisartan or amlodipine alone. It helps improve essential hypertension, which is a condition where blood pressure rises without a specific cause. Proper blood pressure management is crucial for reducing the risk of cardiovascular diseases and maintaining overall health, so this medication assists in controlling blood pressure.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.

Child dose

Pediatric patients 18 years of age or younger: The safety and efficacy of this medicine have not been established; therefore, its use is not recommended.

Precautions

This medication should not be used in pregnant women, especially in the second and third trimesters, as it may pose serious risks to the fetus. It should not be administered to patients who are allergic to the active ingredient or similar substances, patients with severe liver impairment or obstructive biliary diseases, severe hypotension, or patients with significantly reduced cardiac function. Patients with primary aldosteronism, certain heart valve diseases, decreased liver function, gastrointestinal diseases, renal vascular diseases, those undergoing dialysis, and the elderly should use this medication with special caution. Various side effects such as dizziness, peripheral edema, headache, dyspepsia, etc. may occur, and if any unusual symptoms appear, consult a healthcare professional immediately. Avoid using this medication during pregnancy, and if pregnancy is confirmed, discontinue use as soon as possible and seek alternative treatment. Since blood pressure may drop too low, if symptoms of hypotension occur at the beginning of treatment, appropriate measures should be taken, and potassium levels and kidney function should be monitored regularly. This medication may interact with other drugs, so inform your doctor or pharmacist of any current medications. It is advisable for breastfeeding women to avoid taking this medication, and it is not recommended for children and adolescents as safety and efficacy have not been sufficiently established. In the case of overdose, symptoms such as hypotension, dizziness, and heart rate changes may occur, so immediate medical attention should be sought. This medication should be kept out of reach of children, stored in its sealed state, and transferred to other containers should be avoided.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 99 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusional state
  • drowsiness
  • headache
  • sensory disturbances
  • sensory loss
  • dysgeusia
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • intestinal gas retention
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • sweating
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic dermal rash
  • drug eruption
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • back pain
  • limb pain
  • tendon pain
  • renal impairment
  • urinary disorders
  • frequent urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • elevated blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • elevated blood creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be kept in a container that is not exposed to light. Additionally, it is best to store the medication at room temperature between 1 and 30 degrees Celsius to maintain its effectiveness and safety.

Appearance and packaging

Appearance

Biconvex oval double-coated tablet in white and pale blue.

Package unit

30 tablets/box [10 tablets/PTP*3], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.